Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities.

Wei Y, McCormick A, MacKenzie A, O'Ferrall E, Venance S, Mah JK, Selby K, McMillan HJ, Smith G, Oskoui M, Hogan G, McAdam L, Mabaya G, Hodgkinson V, Lounsberry J, Korngut L, Campbell C.

Paediatr Child Health. 2018 Feb;23(1):20-26. doi: 10.1093/pch/pxx125. Epub 2017 Dec 8.

PMID:
29479275
2.

Evolving Motivations: Patients' and Caregivers' Perceptions About Seeking Myotonic Dystrophy (DM1) and Huntington's Disease Care.

LaDonna KA, Watling CJ, Ray SL, Piechowicz C, Venance SL.

Qual Health Res. 2017 Sep;27(11):1727-1737. doi: 10.1177/1049732317711901. Epub 2017 Jun 19.

PMID:
28799481
3.

Survey of Canadian Myotonic Dystrophy Patients' Access to Computer Technology.

Climans SA, Piechowicz C, Koopman WJ, Venance SL.

Can J Neurol Sci. 2017 Sep;44(5):567-571. doi: 10.1017/cjn.2017.47. Epub 2017 May 24.

PMID:
28535832
4.

Approach to the Patient With HyperCKemia.

Venance SL.

Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1803-1814. Review.

PMID:
27922494
5.

Myotonic Dystrophy and Huntington's Disease Care: "We Like to Think We're Making a Difference".

LaDonna KA, Watling CJ, Ray SL, Piechowicz C, Venance SL.

Can J Neurol Sci. 2016 Sep;43(5):678-86. doi: 10.1017/cjn.2016.257.

PMID:
27670211
6.

Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel.

Tarnopolsky M, Katzberg H, Petrof BJ, Sirrs S, Sarnat HB, Myers K, Dupré N, Dodig D, Genge A, Venance SL, Korngut L, Raiman J, Khan A.

Can J Neurol Sci. 2016 Jul;43(4):472-85. doi: 10.1017/cjn.2016.37. Epub 2016 Apr 8. Review.

PMID:
27055517
7.

Hard to Swallow: A Phenomenological Exploration of the Experience of Caring for Individuals With Myotonic Dystrophy and Dysphagia.

LaDonna KA, Koopman WJ, Ray SL, Venance SL.

J Neurosci Nurs. 2016 Feb;48(1):42-51. doi: 10.1097/JNN.0000000000000178.

PMID:
26720320
8.

Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.

LaDonna KA, Venance SL.

J Neurosci Nurs. 2015 Oct;47(5):285-95. doi: 10.1097/JNN.0000000000000160.

PMID:
26348433
9.

Truths and misinformation: a qualitative exploration of myotonic dystrophy.

LaDonna KA, Ghavanini AA, Venance SL.

Can J Neurol Sci. 2015 May;42(3):187-94. doi: 10.1017/cjn.2015.26. Epub 2015 Apr 13.

PMID:
25867706
10.

The Search for Pompe Patients in Canada: Assessing Feasibility of a National Disease Registry to Facilitate Research.

Korngut L, Johnston M, Campbell C, Genge A, MacKenzie A, McCormick A, Venance S.

J Neuromuscul Dis. 2015;2(s1):S45-S46. No abstract available.

PMID:
27858639
11.

Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.

Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, van Doorn PA.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1331-6. doi: 10.1136/jnnp-2014-309042. Epub 2014 Dec 16.

PMID:
25515502
12.

Exploring frontline faculty perspectives after a curriculum change.

Venance SL, LaDonna KA, Watling CJ.

Med Educ. 2014 Oct;48(10):998-1007. doi: 10.1111/medu.12529.

PMID:
25200020
13.

The CNDR: collaborating to translate new therapies for Canadians.

Korngut L, Campbell C, Johnston M, Benstead T, Genge A, Mackenzie A, McCormick A, Biggar D, Bourque P, Briemberg H, O'Connell C, Dojeiji S, Dooley J, Grant I, Hogan G, Johnston W, Kalra S, Katzberg HD, Mah JK, McAdam L, McMillan HJ, Melanson M, Selby K, Shoesmith C, Smith G, Venance SL, Wee J; CNDR Investigator Network.

Can J Neurol Sci. 2013 Sep;40(5):698-704.

PMID:
23968944
14.

Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.

Trivedi JR, Bundy B, Statland J, Salajegheh M, Rayan DR, Venance SL, Wang Y, Fialho D, Matthews E, Cleland J, Gorham N, Herbelin L, Cannon S, Amato A, Griggs RC, Hanna MG, Barohn RJ; CINCH Consortium.

Brain. 2013 Jul;136(Pt 7):2189-200. doi: 10.1093/brain/awt133. Epub 2013 Jun 13.

15.

Congenital myotonic dystrophy: Canadian population-based surveillance study.

Campbell C, Levin S, Siu VM, Venance S, Jacob P.

J Pediatr. 2013 Jul;163(1):120-5.e1-3. doi: 10.1016/j.jpeds.2012.12.070. Epub 2013 Feb 14.

PMID:
23415617
16.

Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.

Statland JM, Bundy BN, Wang Y, Rayan DR, Trivedi JR, Sansone VA, Salajegheh MK, Venance SL, Ciafaloni E, Matthews E, Meola G, Herbelin L, Griggs RC, Barohn RJ, Hanna MG; Consortium for Clinical Investigation of Neurologic Channelopathies.

JAMA. 2012 Oct 3;308(13):1357-65. doi: 10.1001/jama.2012.12607.

17.

A quantitative measure of handgrip myotonia in non-dystrophic myotonia.

Statland JM, Bundy BN, Wang Y, Trivedi JR, Raja Rayan D, Herbelin L, Donlan M, McLin R, Eichinger KJ, Findlater K, Dewar L, Pandya S, Martens WB, Venance SL, Matthews E, Amato AA, Hanna MG, Griggs RC, Barohn RJ; CINCH Consortium.

Muscle Nerve. 2012 Oct;46(4):482-9. doi: 10.1002/mus.23402.

18.

Decomposition-based quantitative electromyography in the evaluation of muscular dystrophy severity.

Derry KL, Venance SL, Doherty TJ.

Muscle Nerve. 2012 Apr;45(4):507-13. doi: 10.1002/mus.22341.

PMID:
22431083
19.

An interactive voice response diary for patients with non-dystrophic myotonia.

Statland JM, Wang Y, Richesson R, Bundy B, Herbelin L, Gomes J, Trivedi J, Venance S, Amato A, Hanna M, Griggs R, Barohn RJ; Cinch Consortium.

Muscle Nerve. 2011 Jul;44(1):30-5. doi: 10.1002/mus.22007.

20.

Myotonic dystrophy (DM1) and dysphagia: the need for dysphagia management guidelines and an assessment tool.

LaDonna KA, Koopman WJ, Venance SL.

Can J Neurosci Nurs. 2011;33(1):42-6. Review.

PMID:
21560885
21.

Clinical features of facioscapulohumeral muscular dystrophy 2.

de Greef JC, Lemmers RJ, Camaño P, Day JW, Sacconi S, Dunand M, van Engelen BG, Kiuru-Enari S, Padberg GW, Rosa AL, Desnuelle C, Spuler S, Tarnopolsky M, Venance SL, Frants RR, van der Maarel SM, Tawil R.

Neurology. 2010 Oct 26;75(17):1548-54. doi: 10.1212/WNL.0b013e3181f96175.

22.

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Matthews E, Fialho D, Tan SV, Venance SL, Cannon SC, Sternberg D, Fontaine B, Amato AA, Barohn RJ, Griggs RC, Hanna MG; CINCH Investigators.

Brain. 2010 Jan;133(Pt 1):9-22. doi: 10.1093/brain/awp294. Epub 2009 Nov 16. Review.

23.

Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD.

de Greef JC, Lemmers RJ, van Engelen BG, Sacconi S, Venance SL, Frants RR, Tawil R, van der Maarel SM.

Hum Mutat. 2009 Oct;30(10):1449-59. doi: 10.1002/humu.21091.

PMID:
19728363
24.

Phenotype of combined Duchenne and facioscapulohumeral muscular dystrophy.

Korngut L, Siu VM, Venance SL, Levin S, Ray P, Lemmers RJ, Keith J, Campbell C.

Neuromuscul Disord. 2008 Jul;18(7):579-82. doi: 10.1016/j.nmd.2008.03.011. Epub 2008 Jun 30.

PMID:
18586493
25.

Challenges in the design and conduct of therapeutic trials in channel disorders.

Venance SL, Herr BE, Griggs RC.

Neurotherapeutics. 2007 Apr;4(2):199-204. Review.

PMID:
17395129
26.

Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.

Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R.

Neurology. 2007 Feb 20;68(8):569-77. Epub 2006 Dec 6.

PMID:
17151338
27.

The primary periodic paralyses: diagnosis, pathogenesis and treatment.

Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, Tristani-Firouzi M, Tawil R, Griggs RC; CINCH investigators.

Brain. 2006 Jan;129(Pt 1):8-17. Epub 2005 Sep 29. Review.

PMID:
16195244
28.

Rigid spine muscular dystrophy due to SEPN1 mutation presenting as cor pulmonale.

Venance SL, Koopman WJ, Miskie BA, Hegele RA, Hahn AF.

Neurology. 2005 Jan 25;64(2):395-6. No abstract available.

PMID:
15668457
29.

SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide.

Venance SL, Jurkat-Rott K, Lehmann-Horn F, Tawil R.

Neurology. 2004 Nov 23;63(10):1977. Review. No abstract available.

PMID:
15557532
30.

Paraspinal atrophy in post-radiation lumbosacral radiculoplexopathy.

Venance SL, Nicolle MW.

J Clin Neuromuscul Dis. 2003 Sep;5(1):49-50. No abstract available.

PMID:
19078721
31.
32.

The clinical and pathologic manifestations of iatrogenically produced mesothelium-rich fragments of operative debris.

Walley VM, Peters HJ, Veinot JP, Courtice RW, Venance SL.

Eur J Cardiothorac Surg. 1997 Feb;11(2):328-32. Review.

PMID:
9080163
33.

Contraction bands in visceral and vascular smooth muscle.

Venance SL, Burns KL, Veinot JP, Walley VM.

Hum Pathol. 1996 Oct;27(10):1035-41.

PMID:
8892587
34.

Giant desmosomes in tumors.

Ghadially FN, Rippstein PU, Cavell S, Venance SL.

Ultrastruct Pathol. 1995 Nov-Dec;19(6):469-74.

PMID:
8597201
35.

CD30 positive (Ki-1) large cell lymphoma presenting with pericardial constriction.

Venance SL, Walley VM, Burns BF, Veinot JP, Hendry P, Smith S.

Cardiovasc Pathol. 1995 Apr-Jun;4(2):141-5.

PMID:
25850913
36.
37.

Forskolin and isoproterenol effect discrete responses on epidermal growth factor induced DNA synthesis in aortic smooth muscle cells.

Venance SL, Bennett BM, Pang SC.

Can J Physiol Pharmacol. 1993 Oct-Nov;71(10-11):800-5.

PMID:
7511481
38.
39.
40.

Enhanced chemiluminescence with catalyzed reporter deposition for increasing the sensitivity of western blotting.

Wigle DA, Radakovic NN, Venance SL, Pang SC.

Biotechniques. 1993 Apr;14(4):562-3. No abstract available.

PMID:
8476597
41.

Cultured smooth muscle approach in the study of hypertension.

Pang SC, Venance SL.

Can J Physiol Pharmacol. 1992 Apr;70(4):573-9. Review.

PMID:
1498722

Supplemental Content

Loading ...
Support Center